COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Intra-coronary Versus Intramyocardial Application of Enriched CD133pos Autologous Bone Marrow Derived Stem Cells (AlsterMACS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01337011
Recruitment Status : Terminated (study was stopped due to funding issues)
First Posted : April 18, 2011
Last Update Posted : March 27, 2018
Miltenyi Biomedicine GmbH
Information provided by (Responsible Party):
Dr. Kai Jaquet, Asklepios proresearch

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2, 2016
Actual Study Completion Date : July 17, 2017